Combo of Cabozantinib With Abiraterone in Chemotherapy-Naïve Subjects With Bone-Metastatic CRPC
Part of paid clinical trials in Scottsdale, Arizona.
- Sponsor
- Exelixis
- Study ID
- NCT01995058
- Phase
- PHASE2
- Status
- Terminated
Conditions
- Castration Resistant Prostate Cancer
- Prostate Cancer
- Prostatic Neoplasms
Eligibility Criteria
- Sex
- MALE
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- cabozantinib — DRUG
- abiraterone — DRUG
- prednisone — DRUG
Study Details
This study was conducted in subjects in chemotherapy-naïve subjects with bone-metastatic castration-resistant prostate cancer (CRPC).
Key Dates
- Start date
- Feb 28, 2014
- Status verified
- Dec 2025
- Primary completion
- Nov 30, 2014
- Completion
- Nov 30, 2014
Study Design
- Enrollment
- 54 participants (actual)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- TREATMENT
Arms
- Experimental: Arm 1: Cabozantinib 40 mg + abiraterone with prednisoneCabozantinib 40 mg, by mouth daily (po QD), + abiraterone with prednisone
- Experimental: Arm 2: Cabozantinib 20 mg + abiraterone and prednisoneCabozantinib 20 mg, by mouth daily (po QD), + abiraterone with prednisone
- Experimental: Arm 3: Cabozantinib 20 mg (every other day) + abiraterone and prednisoneCabozantinib 20 mg every other day with abiraterone and prednisone
- Active Comparator: Arm 4: Abiraterone and prednisone onlyAbiraterone with prednisone
Primary Outcome Measure
Radiographic Progression Free Survival (PFS) [ Time Frame: Up to 18 Months ]
Locations (20)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| - | Scottsdale | Arizona | 85258 | - |
| - | Sedona | Arizona | 86336 | - |
| - | Tucson | Arizona | 85710 | - |
| - | Oxnard | California | 93030 | - |
| - | San Diego | California | 92108 | - |
| - | Aurora | Colorado | 80012 | - |
| - | Aurora | Colorado | 80045 | - |
| - | Athens | Georgia | 30607 | - |
| - | Atlanta | Georgia | 30318 | - |
| - | Peoria | Illinois | 61615 | - |
| - | Wichita | Kansas | 67214 | - |
| - | Las Vegas | Nevada | 89148 | - |
| - | Raleigh | North Carolina | 27607 | - |
| - | Tualatin | Oregon | 97062 | - |
| - | Charleston | South Carolina | 29414 | - |
| - | Greenville | South Carolina | 29605 | - |
| - | Myrtle Beach | South Carolina | 29572 | - |
| - | Dallas | Texas | 75246 | - |
| - | Houston | Texas | 77024 | - |
| - | Salt Lake City | Utah | 84112 | - |
Find similar trials in Scottsdale, AZ
By condition
By specialty
Related Studies
- Prostate Active Surveillance StudyRecruiting · University of Washington · San Francisco, California
- Active Surveillance for Cancer of the Prostate (ASCaP)Recruiting · Jonsson Comprehensive Cancer Center · Los Angeles, California
- Postoperative or Salvage Radiotherapy (RT) for Node Negative Prostate Cancer Following Radical ProstatectomyRecruiting · Proton Collaborative Group · Little Rock, Arkansas
- Hypo-fractionated Radiation Therapy With or Without Androgen Suppression for Intermediate Risk Prostate CancerPHASE3 · Recruiting · Proton Collaborative Group · Scottsdale, Arizona